Kurs Repros Therapeutics Inc

Aktien

26.01.18	Repros Announces Negative Opinion From the EMA for Enclomiphene
15.12.17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency
12.12.17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout
12.12.17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders
12.12.17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

Zu einer Liste hinzufügen 0 ausgewählt Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein Einloggen Anmeldung	%	% 5 Tage	% 1 Jahr	Veränd. 3 Jahre	Kap.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
LONZA GROUP AG	-2.54%	-2.84%	-1.77%	+14.72%	48.93 Mrd.
REVOLUTION MEDICINES, INC.	-0.40%	+1.03%	+418.57%	+523.39%	45.01 Mrd.
IQVIA HOLDINGS INC.	-1.42%	+2.30%	+42.67%	+21.22%	44.07 Mrd.
BEONE MEDICINES AG	-1.22%	-2.31%	+4.82%	+74.90%	40.73 Mrd.
CELLTRION, INC.	+0.53%	-1.36%	+16.87%	+47.12%	33.52 Mrd.
ASCENDIS PHARMA A/S	-0.21%	+9.14%	-	-	17.77 Mrd.
MEDPACE HOLDINGS, INC.	-0.35%	-1.56%	+21.42%	+123.04%	16.5 Mrd.
EUROFINS SCIENTIFIC SE	-1.01%	+0.50%	+13.91%	+31.45%	14.67 Mrd.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.65%	-1.03%	+75.93%	+41.22%	13.77 Mrd.
Durchschnitt	-0.83%	+0.53%	+74.05%	+109.63%	30.55 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung	-1.03%	+0.11%	+89.42%	+127.93%

Beschäftigte

Sektor